Composition and health effects of phenolic compounds in hawthorn (Crataegus spp.) of different origins

Journal of the Science of Food and Agriculture

Volumn 92, Issue 8, 2012, Pages 1578-1590

  Yang, Baoru ^a   Liu, Pengzhan ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Biological activities; Composition; Crataegus spp.; Hawthorn; Phenolic compounds

Indexed keywords

PHENOL DERIVATIVE; PLANT EXTRACT;

ANIMAL; CHEMISTRY; CRATAEGUS; EXERCISE; GENETICS; GENOTYPE; HEART FAILURE; HUMAN; PHYTOTHERAPY; PLANT STRUCTURES; REVIEW;

ANIMALS; CRATAEGUS; EXERCISE; GENOTYPE; HEART FAILURE; HUMANS; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT STRUCTURES;

ANIMALIA; CRATAEGUS;

EID: 84859888778     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.5671     Document Type: Review

References (76)

1. Zhao H and Tian B, China Fruit-plant Monograph, Hawthorn Flora. Zhongguo Linye Press, Beijing, pp. 13-15 (1996).
2. China Pharmacopoeia Committee, Chinese Pharmacopoeia. Chemical Industry Press, Beijing, pp. 25-26 (2005).
3. Chang Q, Zuo Z, Harrison F and Chow MSS, Hawthorn. J Clin Pharmacol 42: 605-612 (2002).
4. Liu P, Yang B and Kallio H, Phenolic compounds in hawthorn (Crataegus grayana) fruits and leaves and changes during fruit ripening. J Agric Food Chem 59: 11141-11145 (2011).
5. Svedström U, Vuorela H, Kostiainen R, Huovinen K, Laakso I and Hiltunen R, High-performance liquid chromatographic determination of oligomeric procyanidins from dimers up to the hexamer in hawthorn. J Chromatogr A 968: 53-60 (2002).
6. Svedström U, Vuorela H, Kostiainen R, Tuominen J, Kokkonen J, Rauha J, et al, Isolation and identification of oligomeric procyanidins from Crataegus leaves and flowers. Phytochemistry 60: 821-825 (2002).
7. Liu P, Yang B and Kallio H, Characterization of phenolic compounds in Chinese hawthorn (Crataegus pinnatifida Bge. var. major) fruit by high performance liquid chromatography-electrospray ionization mass spectrometry. Food Chem 121: 1188-1197 (2010).
8. Liu P, Kallio H, Lü D, Zhou C and Yang B, Quantitative analysis of phenolic compounds in Chinese hawthorn (Crataegus spp.) fruits by high performance liquid chromatography-electrospray ionisation mass spectrometry. Food Chem 127: 1370-1377 (2011).
9. Cui T, Nakamura K, Tian S, Kayahara H and Tian Y, Polyphenolic content and physiological activities of Chinese hawthorn extracts. Biosci Biotechnol Biochem 70: 2948-2956 (2006).
10. Cui T, Li J, Kayahara H, Ma L, Wu L and Nakamura K, Quantification of the polyphenols and triterpene acids in Chinese hawthorn fruit by high-performance liquid chromatography. J Agric Food Chem 54: 4574-4581 (2006).
11. Rohr GE, Meier B and Sticher O, Analysis of procyanidins. Stud Nat Prod Chem 21: 497-537 (2000).
12. Bahri-Sahloul R, Ammar S, Fredj RB, Saguem S, Grec S, Trotin F, et al, Polyphenol contents and antioxidant activities of extracts from flowers of two Crataegus azarolus L. varieties. Pak J Biol Sci 12: 660-668 (2009).
13. Svedström U, Vuorela H, Kostiainen R, Laakso I and Hiltunen R, Fractionation of polyphenols in hawthorn into polymeric procyanidins, phenolic acids and flavonoids prior to high-performance liquid chromatographic analysis. J Chromatogr A 1112: 103-111 (2006).
14. Frank P and Adolf N, Crataegus from the analytical viewpoint. Official contents of hawthorn drugs. Pharmazie Unserer Zeit 34: 22-26 (2005).
15. Oh I, Whang W and Kim I, Constituents of Crataegus pinnatifida var. psilosa leaves. (II) Flavonoids from BuOH fraction. Arch Pharmacal Res 17: 314-317 (1994).
16. Dauguet J, Bert M, Dolley J, Bekaert A and Lewin G, 8-Methoxykaempferol 3-neohesperidoside and other flavonoids from bee pollen of Crataegus monogyna. Phytochemistry 33: 1503-1505 (1993).
17. Ringl A, Prinz S, Huefner A, Kurzmann M and Kopp B, Chemosystematic value of flavonoids from Crataegus × macrocarpa (Rosaceae) with special emphasis on (R)- and (S)-eriodictyol-7-O-glucuronide and luteolin-7-O-glucuronide. Chem Biodivers 4: 154-162 (2007).
18. Zhang P and Xu S, Chemical constituents from the leaves of Crataegus pinnatifida Bge. var. major N.E.Br. Acta Pharmaceut Sin 36: 754-757 (2001).
19. Zhang P and Xu S, C-Glucoside flavonoids from the leaves of Crataegus pinnatifida Bge. var. major N.E.Br. J Asian Nat Prod Res 5: 131-136 (2003).
20. Prinz S, Ringl A, Huefner A, Pemp E and Kopp B, 4″'-Acetylvitexin-2″-O-rhamnoside, isoorientin, orientin, and 8-methoxykaempferol-3-O-glucoside as markers for the differentiation of Crataegus monogyna and Crataegus pentagyna from Crataegus laevigata (Rosaceae). Chem Biodivers 4: 2920-2931 (2007).
21. Zhang P, Zhou Y and Xu S, Two novel flavonoid glycosides from Crataegus pinnatifida Bge. var. major N.E.Br. J Asian Nat Prod Res 3: 77-82 (2001).
22. Zhang P and Xu S, Flavonoid ketohexosefuranosides from the leaves of Crataegus pinnatifida Bge. var. major N.E.Br. Phytochemistry 57: 1249-1253 (2001).
23. Ma M and Gu Z, Chemical composition of water-soluble fractions of Crataegus cuneata. China Pharmaceut 12: 35-35 (2003).
24. Ma G, Jiang X, Chen Z, Ren J, Li C and Liu T, Simultaneous determination of vitexin-4″-O-glucoside and vitexin-2″-O-rhamnoside from hawthorn leaves flavonoids in rat plasma by HPLC method and its application to pharmacokinetic studies. J Pharmaceut Biomed Anal 44: 243-249 (2007).
25. Zhang Z, Chang Q, Zhu M, Huang Y, Ho WKK and Chen Z, Characterization of antioxidants present in hawthorn fruits. J Nutr Biochem 12: 144-152 (2001).
26. Gao P, Li L, Peng Y, Li F, Niu C, Huang X, et al, Monoterpene and lignan glycosides in the leaves of Crataegus pinnatifida. Biochem Syst Ecol 38: 988-992 (2010).
27. Urbonaviciūte A, Jakstas V, Kornysova O, Janulis V and Maruska A, Capillary electrophoretic analysis of flavonoids in single-styled hawthorn (Crataegus monogyna Jacq.) ethanolic extracts. J Chromatogr A 1112: 339-344 (2006).
28. Peschel W, Bohr C and Plescher A, Variability of total flavonoids in Crataegus-factor evaluation for the monitored production of industrial starting material. Fitoterapia 79: 6-20 (2008).
29. Froehlicher T, Hennebelle T, Martin-Nizard F, Cleenewerck P, Hilbert J, Trotin F, et al, Phenolic profiles and antioxidative effects of hawthorn cell suspensions, fresh fruits, and medicinal dried parts. Food Chem 115: 897-903 (2009).
30. Gao G and Feng Y, Pharmacognosy and resource utilization of Yunnan-hawthorn. Chin Pharmaceut J 29: 329-331 (1994).
31. Gao G, Feng Y, Beuscher N, Ehret L and Gerke H, Identification and quality comparison of German and Chinese hawthorn. Chin Pharmaceut J 30: 589-591 (1995).
32. Liu P, Kallio H, Lü D, Zhou C, Ou S and Yang B, Acids, sugars, and sugar alcohols in Chinese hawthorn (Crataegus spp.) fruits. J Agric Food Chem 58: 1012-1019 (2010).
33. Rehwald A, Meier B and Sticher O, Qualitative and quantitative reversed-phase high-performance liquid chromatography of flavonoids in Crataegus leaves and flowers. J Chromatogr A 677: 25-33 (1994).
34. Fong HHS and Bauman JL, Hawthorn. J Cardiovasc Nurs 16: 1-8 (2002).
35. Rigelsky JM and Sweet BV, Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm 59: 417-422 (2002).
36. Furey A and Tassell M, Towards a systematic scientific approach in the assessment of efficacy of an herbal preparation: hawthorn (Crataegus spp.). Eur J Heart Fail 10: 1153-1157 (2008).
37. Pittler MH, Schmidt K and Ernst E, Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 114: 665-674 (2003).
38. Guo R, Pittler MH and Ernst E, Hawthorn extract for treating chronic heart failure. Cochrane Database of Systematic Reviews 2008, Issue 1 (2009). DOI: 10.1002/14651858.CD005312.pub2.
39. Degenring FH, Suter A, Weber M and Saller R, A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II. Phytomedicine 10: 363-369 (2003).
40. Bernatoniene J, Trumbeckaite S, Majiene D, Baniene R, Baliutyte G, Savickas A, et al, The effect of Crataegus fruit extract and some of its flavonoids on mitochondrial oxidative phosphorylation in the heart. Phytother Res 23: 1701-1707 (2009).
41. Swaminathan JK, Khan M, Mohan IK, Selvendiran K, Niranjali Devaraj S, Rivera BK, et al, Cardioprotective properties of Crataegus oxyacantha extract against ischemia-reperfusion injury. Phytomedicine 17: 744-752 (2010).
42. Frey N and Olson EN, Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65: 45-79 (2003).
43. Hwang HS, Bleske BE, Ghannam MMJ, Converso K, Russell MW, Hunter JC, et al, Effects of hawthorn on cardiac remodeling and left ventricular dysfunction after 1 month of pressure overload-induced cardiac hypertrophy in rats. Cardiovasc Drugs Ther 22: 19-28 (2008).
44. Hwang HS, Boluyt MO, Converso K, Russell MW and Bleske BE, Effects of hawthorn on the progression of heart failure in a rat model of aortic constriction. Pharmacotherapy 29: 639-648 (2009).
45. Long SR, Carey RA, Crofoot KM, Proteau PJ and Filtz TM, Effect of hawthorn (Crataegus oxyacantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine 13: 643-650 (2006).
46. Garjani A, Nazemiyeh H, Maleki N and Valizadeh H, Effects of extracts from flowering tops of Crataegus meyeri A. Pojark. on ischaemic arrhythmias in anaesthetized rats. Phytother Res 14: 428-431 (2000).
47. Ling S, Nheu L, Dai A, Guo Z and Komesaroff P, Effects of four medicinal herbs on human vascular endothelial cells in culture. Int J Cardiol 128: 350-358 (2008).
48. Weintraub WS, The pathophysiology and burden of restenosis. Am J Cardiol 100: S3-S9 (2007).
49. Fürst R, Zirrgiebel U, Totzke F, Zahler S, Vollmar AM and Koch E, The Crataegus extract WS 1442 inhibits balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing PDGFR-beta. Atherosclerosis 211: 409-417 (2010).
50. Levitzki A, PDGF receptor kinase inhibitors for the treatment of restenosis. Cardiovasc Res 65: 581-586 (2005).
51. Rajendran S, Deepalakshmi PD, Parasakthy K, Devaraj H and Devaraj SN, Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis 123: 235-241 (1996).
52. Zhang Z, Ho WKK, Huang Y, James AE, Lam LW and Chen Z, Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. J Nutr 132: 5-10 (2002).
53. Ye X, Huang W, Chen Z, Li X, Li P, Lan P, et al, Synergetic effect and structure-activity relationship of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors from Crataegus pinnatifida Bge. J Agric Food Chem 58: 3132-3138 (2010).
54. Kuo D, Yeh C, Shieh P, Cheng K, Chen F and Cheng J, Effect of ShanZha, a Chinese herbal product, on obesity and dyslipidemia in hamsters receiving high-fat diet. J Ethnopharmacol 124: 544-550 (2009).
55. Kwok C, Wong CN, Yau MY, Yu PH, Au ALS, Poon CC, et al, Consumption of dried fruit of Crataegus pinnatifida (hawthorn) suppresses high-cholesterol diet-induced hypercholesterolemia in rats. J Funct Foods 2: 179-186 (2010).
56. Fan C, Yan J, Qian Y, Wo X and Gao L, Regulation of lipoprotein lipase expression by effect of hawthorn flavonoids on peroxisome proliferator response element pathway. J Pharmacol Sci 100: 51-58 (2006).
57. Chen Z, Zhang Z, Kwan K, Zhu M, Ho WK and Huang Y, Endothelium-dependent relaxation induced by hawthorn extract in rat mesenteric artery. Life Sci 63: 1983-1991 (1998).
58. Brixius K, Willms S, Napp A, Tossios P, Ladage D, Bloch W, et al, Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther 20: 177-184 (2006).
59. Koçyildiz ZC, Birman H, Olgaç V, Akgün-Dar K, Melikoǧlu G and Meriçli AH, Crataegus tanacetifolia leaf extract prevents L-NAME-induced hypertension in rats: a morphological study. Phytother Res 20: 66-70 (2006).
60. Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M, et al, Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract 56: 437-443 (2006).
61. Asgary S, Naderi GH, Sadeghi M, Kelishadi R and Amiri M, Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomized, double-blind study. Drugs Exp Clin Res 30: 221-225 (2004).
62. Guo C, Yang J, Wei J, Li Y, Xu J and Jiang Y, Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay. Nutr Res 23: 1719-1726 (2003).
63. Ebrahimzadeh MA and Bahramian F, Antioxidant activity of Crataegus pentagyna subsp. elburensis fruits extracts used in traditional medicine in Iran. Pak J Biol Sci 12: 413-419 (2009).
64. Bernatoniene J, Masteikova R, Majiene D, Savickas A, Kevelaitis E, Bernatoniene R, et al, Free radical-scavenging activities of Crataegus monogyna extracts. Medicina (Kaunas) 44: 706-712 (2008).
65. Periera da Silva A, Rocha R, Silva CM, Mira L, Duarte MF and Florêncio MH, Antioxidants in medicinal plant extracts. A research study of the antioxidant capacity of Crataegus, Hamamelis and Hydrastis. Phytother Res 14: 612-616 (2000).
66. Ljubuncic P, Portnaya I, Cogan U, Azaizeh H and Bomzon A, Antioxidant activity of Crataegus aronia aqueous extract used in traditional Arab medicine in Israel. J Ethnopharmacol 101: 153-161 (2005).
67. Chu C, Lee M, Liao C, Lin W, Yin Y and Tseng T, Inhibitory effect of hot-water extract from dried fruit of Crataegus pinnatifida on low-density lipoprotein (LDL) oxidation in cell and cell-free systems. J Agric Food Chem 51: 7583-7588 (2003).
68. Jin N and Liu T, Antioxidant activity of procyanidins from hawthorn fruit. Food Ferment Ind 33: 45-47 (2007).
69. Toide K, Shinoda M and Miyazaki A, A novel prolyl endopeptidase inhibitor, JTP-4819-its behavioral and neurochemical properties for the treatment of Alzheimer's disease. Rev Neurosci 9: 17-29 (1998).
70. Hosseinimehr SJ, Azadbakht M, Mousavi SM, Mahmoudzadeh A and Akhlaghpoor S, Radioprotective effects of hawthorn fruit extract against gamma irradiation in mouse bone marrow cells. J Radiat Res 48: 63-68 (2007).
71. Kao E, Wang C, Lin W, Yin Y, Wang C and Tseng T, Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo. J Agric Food Chem 53: 430-436 (2005).
72. Duval DL, Miller DR, Collier J and Billings RE, Characterization of hepatic nitric oxide synthase: identification as the cytokine-inducible form primarily regulated by oxidants. Mol Pharmacol 50: 277-284 (1996).
73. Zhang C, Walker LM, Hinson JA and Mayeux PR, Oxidant stress in rat liver after lipopolysaccharide administration: effect of inducible nitric-oxide synthase inhibition. J Pharmacol Exp Ther 293: 968-972 (2000).
74. Kao E, Wang C, Lin W, Chu C and Tseng T, Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application. Food Chem Toxicol 45: 1795-1804 (2007).
75. Tadić VM, Dobrić S, Marković GM, Dordević SM, Arsić IA, Menković NR, et al, Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. J Agric Food Chem 56: 7700-7709 (2008).
76. Liu R and Yu B, HPLC fingerprint chromatogram of leaves of hawthorn. Chin Tradit Patent Med 29: 7-11 (2007).